Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Rocket Pharmaceuticals (RCKT – Research Report) today. The ...

The firm sees smaller vendors, point solutions, and those leaning on contact center as a key growth vector as those most at-risk. Overarching theme impacting this category is intensifying competition ...